TY - JOUR
T1 - Xanthomonas maltophilia bacteremia
T2 - An analysis of factors influencing outcome
AU - Noskin, Gary A.
AU - Grohmann, Stephen M.
PY - 1992/7
Y1 - 1992/7
N2 - Xanthomonas maltophilia has emerged as an important nosocomial pathogen, particularly in immunocompromised patients. In this retrospective analysis, the clinical and epidemiologic factors as well as the response to therapy in patients with xanthomonas bacteremia are examined. During a 6-year period, 24 patients had bacteremia with this organism. The crude mortality rate was 42%. There was no difference in outcome on the basis of sex, age, underlying disease, polymicrobial bacteremia, total leukocyte count, or absolute neutrophil count. Statistically significant differences in mortality were observed in patients with a pulmonary source of infection, septic shock, or inappropriate antimicrobial therapy. The isolates were uniformly resistant to the extended-spectrum penicillins and cephalosporins, except cefoperazone and ceftazidime. Three quarters of the isolates were resistant to all aminoglycosides tested. X. maltophilia bacteremia is an important cause of morbidity and mortality, and antibiotic therapy should be based on in vitro susceptibility.
AB - Xanthomonas maltophilia has emerged as an important nosocomial pathogen, particularly in immunocompromised patients. In this retrospective analysis, the clinical and epidemiologic factors as well as the response to therapy in patients with xanthomonas bacteremia are examined. During a 6-year period, 24 patients had bacteremia with this organism. The crude mortality rate was 42%. There was no difference in outcome on the basis of sex, age, underlying disease, polymicrobial bacteremia, total leukocyte count, or absolute neutrophil count. Statistically significant differences in mortality were observed in patients with a pulmonary source of infection, septic shock, or inappropriate antimicrobial therapy. The isolates were uniformly resistant to the extended-spectrum penicillins and cephalosporins, except cefoperazone and ceftazidime. Three quarters of the isolates were resistant to all aminoglycosides tested. X. maltophilia bacteremia is an important cause of morbidity and mortality, and antibiotic therapy should be based on in vitro susceptibility.
UR - http://www.scopus.com/inward/record.url?scp=0347472578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0347472578&partnerID=8YFLogxK
U2 - 10.1097/00019048-199207000-00003
DO - 10.1097/00019048-199207000-00003
M3 - Article
AN - SCOPUS:0347472578
SN - 1056-9103
VL - 1
SP - 230
EP - 236
JO - Infectious Diseases in Clinical Practice
JF - Infectious Diseases in Clinical Practice
IS - 4
ER -